ClinicalTrials.gg
RecruitingNCT07191314Updated Nov 18, 2026

Long-term Evaluation of a Nasopharyngeal Airway

An interventional study of nasopharyngeal airway obstructive sleep apnea (NPA-OSA) device in Sleep Apnea, Obstructive, sponsored by University of Michigan. Recruiting at 2 sites in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-18.

Sponsored by University of Michigan · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Oct 2025; still recruiting 1 year 1 month later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 21 studies in Sleep Apnea, Obstructive by University of Michigan — 5 open to participants now, 5 under way, none of them phase 3. Sleep Apnea, Obstructive · University of Michigan.

Planned enrollment
13th of 17
20 · median 40
Started
2025
with 1 other
No phase
13 of 21
5 open now
Registered
21st of 21
by date

Among the 21 studies in Sleep Apnea, Obstructive by University of Michigan, this one is the 13th largest by planned enrollment of the 17 interventional ones that give a count, is one of 2 that started in 2025, is one of 13 with no phase, and was the 21st registered.

Sleep Apnea, Obstructive

2,246 studies on the registry are indexed under Sleep Apnea, Obstructive; 476 are open to participants now.

Browse Sleep Apnea, Obstructive studies →

Open to participants now

5 of the 21 studies in Sleep Apnea, Obstructive by University of Michigan are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 5 open studies →

Where they have run

Who these studies take

Of the 317 Sleep Apnea, Obstructive studies recruiting now, 149 (47%) set no upper age limit and 124 (39%) stop at 75 or younger; 53 take children under 18; 66 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 21 studies in Sleep Apnea, Obstructive by University of Michigan, or all of them as a file.
02

Study summary

This long-term follow-up study will permit continued device use for participants of the parent study (NCT06677151).

During study participation the study team will stay in contact with participants as necessary. Additionally, patients will undergo clinical follow-up as needed with their physician(s). At 12 months, participants will complete sleep questionnaires as part of this long-term follow-up period.

03

Conditions studied

  • Sleep Apnea, Obstructive

Keywords

  • nasopharyngeal
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

-Participants who completed the parent study (HUM00179497) and wish to continue using the NPA-OSA device.

Exclusion criteria

Exclusion Criteria:

  • The participants who were non-compliant with the NPA-OSA device during their participation in the parent study.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
20 participants (estimated)

Study arms

  • Experimental
    Nasopharyngeal airway device

    A nasopharyngeal airway obstructive sleep apnea ("NPA"-OSA) device will be used for two years at home.

    Device: nasopharyngeal airway obstructive sleep apnea (NPA-OSA) device

Interventions

  • Devicenasopharyngeal airway obstructive sleep apnea (NPA-OSA) device

    The NPA-OSA is a flexible, medical-grade silicone, tube-like device that is self-inserted into the user's nasopharyngeal airway through one nostril prior to sleep and worn throughout the night to reduce or alleviate snoring and obstructive sleep apnea.

06

What researchers measure

Primary outcomes

  1. Change in severity of apnea hypopnea index (AHI)

    The AHI is calculated by dividing the number of apnea events by the number of hours of sleep.

    Time frame: Baseline (day 0), 24 months

07

Study locations

2 of 2 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Oct 2025 (actual). Primary completion is estimated for Sep 2027, 23 months after the start.

Of 511 non-industry interventional studies with no phase under Sleep Apnea, Obstructive, half reached primary completion within 33 months of starting (the median), counting those still running; a quarter within 17 and three quarters within 53. This study's planned 23 months is below that.

Counting every sponsor, half of 629 studies reached it within 27 months; a quarter within 12 and three quarters within 50.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 17, 2025
First posted
Sep 24, 2025
StartActual
Oct 21, 2025
Primary completionEst.
Sep 2027
CompletionEst.
Sep 2027
Last update
Nov 18, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Minor edits
Nothing that changes what the study is or who can join. Edited: verification date
1 update, last Nov 18, 2026
Show all 1 update
  1. Nov 18, 2026
    Minor edits only
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07191314
Collaborators
Wallace H Coulter Center for Translational Research
Responsible party
Louise O'Brien (Professor, Sleep Medicine, University of Michigan) — Principal investigator
First posted
Sep 24, 2025
Start date
Oct 21, 2025
Primary completion
Sep 2027 (estimated)
Completion
Sep 2027 (estimated)
Last update
Nov 18, 2026

Study contacts

Zahra Nourmohammadi, PhD
Contact
znourmoh@med.umich.edu
734 936-9816
Louise M O'Brien, PhD
Contact
louiseo@med.umich.edu
734 647-9064
Louise M O'Brien, PhD
principal investigator · University of Michigan
David Zopf, MD, MS
principal investigator · University of Wisconsin, Madison

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion